Cargando…
Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1
Acute lung injury (ALI) is a severe inflammatory disease for which no specific treatment exists. As glucocorticoids have potent immunosuppressive effects, their application in ALI is currently being tested in clinical trials. However, the benefits of this type of regimen remain unclear. Here we iden...
Autores principales: | Vettorazzi, Sabine, Bode, Constantin, Dejager, Lien, Frappart, Lucien, Shelest, Ekaterina, Klaßen, Carina, Tasdogan, Alpaslan, Reichardt, Holger M., Libert, Claude, Schneider, Marion, Weih, Falk, Henriette Uhlenhaut, N., David, Jean-Pierre, Gräler, Markus, Kleiman, Anna, Tuckermann, Jan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518295/ https://www.ncbi.nlm.nih.gov/pubmed/26183376 http://dx.doi.org/10.1038/ncomms8796 |
Ejemplares similares
-
Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget
por: Hatoum, Diana, et al.
Publicado: (2017) -
Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases
por: Bu, Yanhong, et al.
Publicado: (2021) -
Inhibition of SphK1 reduces radiation-induced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR/SphK1 crosstalk
por: Schiefler, Carlotta, et al.
Publicado: (2014) -
SphK2 over-expression promotes osteosarcoma cell growth
por: Xu, Dawei, et al.
Publicado: (2017) -
Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma
por: Shi, Weiwei, et al.
Publicado: (2020)